{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:10:22Z","timestamp":1785885022044,"version":"3.56.0"},"reference-count":35,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:00:00Z","timestamp":1719014400000},"content-version":"unspecified","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["NIHR134800"],"award-info":[{"award-number":["NIHR134800"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,5,1]]},"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Biological disease-modifying antirheumatic drugs (bDMARDs) have revolutionised the treatment of inflammatory arthritis (IA). However, many people with IA still require planned orthopaedic surgery to reduce pain and improve function. Currently, bDMARDs are withheld during the perioperative period due to potential infection risk. However, this predisposes patients to IA flares and loss of disease control. The question of whether to stop or continue bDMARDs in the perioperative period has not been adequately addressed in a randomised controlled trial (RCT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>PERISCOPE is a multicentre, superiority, pragmatic RCT investigating the stoppage or continuation of bDMARDs. Participants will be assigned 1:1 to either stop or continue their bDMARDs during the perioperative period. We aim to recruit 394 adult participants with IA. Potential participants will be identified in secondary care hospitals in the UK, screened by a delegated clinician. If eligible and consenting, baseline data will be collected and randomisation completed. The primary outcome will be the self-reported PROMIS-29 (Patient Reported Outcome Measurement Information System) over the first 12 weeks postsurgery. Secondary outcome measures are as follows: PROMIS - Health Assessment Questionnaire (PROMIS-HAQ), EQ-5D-5L, Disease activity: generic global Numeric Rating Scale (patient and clinician), Self-Administered Patient Satisfaction scale, Health care resource use and costs, Medication use, Surgical site infection, delayed wound healing, Adverse events (including systemic infections) and disease-specific outcomes (according to IA diagnosis). The costs associated with stopping and continuing bDMARDs will be assessed. A qualitative study will explore the patients\u2019 and clinicians\u2019 acceptability and experience of continuation\/stoppage of bDMARDs in the perioperative period and the impact postoperatively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval for this study was received from the West of Scotland Research Ethics Committee on 25 April 2023 (REC Ref: 23\/WS\/0049). The findings from PERISCOPE will be submitted to peer-reviewed journals and feed directly into practice guidelines for the use of bDMARDs in the perioperative period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"ISRCTN17691638\">ISRCTN17691638<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-084997","type":"journal-article","created":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T10:46:07Z","timestamp":1719139567000},"page":"e084997","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["PERI-operative biologic DMARD management: Stoppage or COntinuation during orthoPaEdic operations (the PERISCOPE trial) \u2013 a study protocol for a pragmatic, UK multicentre, superiority randomised controlled trial with an internal pilot, economic evaluation and nested qualitative study"],"prefix":"10.1136","volume":"14","clinical-trial-number":[{"clinical-trial-number":"isrctn17691638","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7763-2776","authenticated-orcid":false,"given":"Samantha","family":"Brady","sequence":"first","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7844-9033","authenticated-orcid":false,"given":"Andrew","family":"Mott","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Carlisle","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0121-4919","authenticated-orcid":false,"given":"Abhishek","family":"Abhishek","sequence":"additional","affiliation":[{"name":"Academic Rheumatology, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9860-0850","authenticated-orcid":false,"given":"Joy","family":"Adamson","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4756-663X","authenticated-orcid":false,"given":"Laura","family":"Coates","sequence":"additional","affiliation":[{"name":"NDORMS, Oxford Brookes University Faculty of Health and Life Sciences, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"van Duren","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7429-8482","authenticated-orcid":false,"given":"Paul","family":"Emery","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK"},{"name":"Leeds NIHR Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan Marion","family":"Goodman","sequence":"additional","affiliation":[{"name":"Cornell University Joan and Sanford I Weill Medical College, New York City, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hewitt","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1496-7450","authenticated-orcid":false,"given":"Jinshuo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mandefield","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Parkinson","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9683-3407","authenticated-orcid":false,"given":"Helena","family":"Marzo-Ortega","sequence":"additional","affiliation":[{"name":"Leeds NIHR Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Maxwell","sequence":"additional","affiliation":[{"name":"Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdeep","family":"Nanchahal","sequence":"additional","affiliation":[{"name":"Kennedy Institute, The University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5452-8578","authenticated-orcid":false,"given":"Amar","family":"Rangan","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"},{"name":"University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Richards","sequence":"additional","affiliation":[{"name":"NDORMS, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ronaldson","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Shepherd","sequence":"additional","affiliation":[{"name":"Leeds NIHR Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5577-3674","authenticated-orcid":false,"given":"Jeremy Mark","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"School of Medicine and Population Health, University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant","family":"Pandit","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK"},{"name":"Chapel Allerton Hospital, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulveer Singh","family":"Mankia","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,6,23]]},"reference":[{"key":"2025121222400592000_14.6.e084997.1","first-page":"736","article-title":"Rheumatoid arthritis is getting less frequent\u2014results of a nationwide population-based cohort study","volume":"56","author":"Abhishek","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2025121222400592000_14.6.e084997.2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket387"},{"key":"2025121222400592000_14.6.e084997.3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.6061\/clinics\/2017(06)09","article-title":"Perioperative management of drugs commonly used in patients with rheumatic diseases: a review","volume":"72","author":"Franco","year":"2017","journal-title":"Clinics (Sao Paulo)"},{"key":"2025121222400592000_14.6.e084997.4","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/acr.23499","article-title":"Orthopedic surgery among patients with rheumatoid arthritis: A population-based study to identify risk factors, sex differences, and time trends","volume":"70","author":"Richter","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025121222400592000_14.6.e084997.5","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.171316"},{"key":"2025121222400592000_14.6.e084997.6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev364"},{"key":"2025121222400592000_14.6.e084997.7","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200453"},{"key":"2025121222400592000_14.6.e084997.8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/107110070402500510","article-title":"Infectious and healing complications after elective Orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy","volume":"25","author":"Bibbo","year":"2004","journal-title":"Foot Ankle Int"},{"key":"2025121222400592000_14.6.e084997.9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew479"},{"key":"2025121222400592000_14.6.e084997.10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.017640"},{"key":"2025121222400592000_14.6.e084997.11","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/acr.24893","article-title":"American college of rheumatology\/American Association of hip and knee Surgeons guideline for the perioperative management of Antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee Arthroplasty","volume":"74","author":"Goodman","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025121222400592000_14.6.e084997.12","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2106\/JBJS.21.00811","article-title":"The effect of perioperative biologic disease-modifying anti-rheumatic drugs on the risk of postoperative complications: surgical site infection, delayed wound healing, and disease flares following Orthopaedic surgical procedures","volume":"104","author":"van Duren","year":"2022","journal-title":"J Bone Joint Surg Am"},{"key":"2025121222400592000_14.6.e084997.13","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/acr.24091","article-title":"Rheumatoid arthritis flares after total hip and total knee Arthroplasty: outcomes at one year","volume":"72","author":"Goodman","year":"2020","journal-title":"Arthritis Care & Research"},{"key":"2025121222400592000_14.6.e084997.14","doi-asserted-by":"publisher","DOI":"10.1002\/art.10524"},{"key":"2025121222400592000_14.6.e084997.15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes305"},{"key":"2025121222400592000_14.6.e084997.16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00393-017-0379-0","article-title":"Perioperative management of immunosuppressive treatment in patients undergoing joint surgery","volume":"76","author":"Kr\u00fcger","year":"2017","journal-title":"Z Rheumatol"},{"key":"2025121222400592000_14.6.e084997.17","unstructured":"NICE . Adalimumab, etanercept, infliximab and abatacept for treating moderate RA after conventional DMARDs have failed, 2021. Available: https:\/\/www.nice.org.uk\/guidance\/ta715"},{"key":"2025121222400592000_14.6.e084997.18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204053"},{"key":"2025121222400592000_14.6.e084997.19","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1002\/art.38759","article-title":"Relative performance of commonly used physical function questionnaires in rheumatoid arthritis and a patient-reported outcomes measurement information system computerized adaptive test","volume":"66","author":"Oude Voshaar","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025121222400592000_14.6.e084997.20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2014.03.1145","article-title":"How well do generic promis fatigue measures perform in rheumatoid arthritis","volume":"17","author":"Bartlett","year":"2014","journal-title":"Value in Health"},{"key":"2025121222400592000_14.6.e084997.21","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/591253","article-title":"The self-administered patient satisfaction scale for primary hip and knee Arthroplasty","volume":"2011","author":"Mahomed","year":"2011","journal-title":"Arthritis"},{"key":"2025121222400592000_14.6.e084997.22","doi-asserted-by":"publisher","DOI":"10.1086\/646436"},{"key":"2025121222400592000_14.6.e084997.23","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200007)43:7<1478::AID-ANR10>3.0.CO;2-M"},{"key":"2025121222400592000_14.6.e084997.24","unstructured":"HealthMeasures Scoring Service, Available: https:\/\/www.assessmentcenter.net\/ac_scoringservice"},{"key":"2025121222400592000_14.6.e084997.25","unstructured":"NHS Digital . n.d. Hrg4+ 2021\/22 national costs Grouper. Available: https:\/\/digital.nhs.uk\/services\/national-casemix-office\/downloads-groupers-and-tools\/hrg4-2021-22-national-costs-grouper"},{"key":"2025121222400592000_14.6.e084997.26","unstructured":"Curtis LA , Burns A . Unit Costs of Health & Social Care 2020. PSSRU, University of Kent, 2020."},{"key":"2025121222400592000_14.6.e084997.27","unstructured":"Department of Health . NHS Reference Costs 2019\/20. 2020."},{"key":"2025121222400592000_14.6.e084997.28","unstructured":"Joint Formulary Committee . BNF 81 (British National Formulary) March 2021. Pharmaceutical Press, 2021."},{"key":"2025121222400592000_14.6.e084997.29","unstructured":"EuroQol Research Foundation . EQ-5D-5L user guide. 2021. Available: https:\/\/euroqol.org\/publications\/user-guides\/"},{"key":"2025121222400592000_14.6.e084997.30","doi-asserted-by":"publisher","DOI":"10.3310\/hta3200"},{"key":"2025121222400592000_14.6.e084997.31","unstructured":"Institute for Health and Care Excellence N . n.d. NICE health technology evaluations: the manual process and methods [Pmg36]."},{"key":"2025121222400592000_14.6.e084997.32","doi-asserted-by":"publisher","DOI":"10.1002\/hec.635"},{"key":"2025121222400592000_14.6.e084997.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.09.2752"},{"key":"2025121222400592000_14.6.e084997.34","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-017-2031-8","article-title":"Acceptability of Healthcare interventions: an overview of reviews and development of a theoretical framework","volume":"17","author":"Sekhon","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"2025121222400592000_14.6.e084997.35","unstructured":"National Institute for Health and Care Excellence (NICE) . Guide to the methods of technology appraisal 2013, 2013. Available: https:\/\/www.nice.org.uk\/process\/pmg9\/chapter\/foreword"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-084997","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:40:16Z","timestamp":1765608016000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-084997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,23]]},"published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10.1136\/bmjopen-2024-084997"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-084997","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]}}}